Clinical Trials Browser

Phase 3 × Glutamine × Thoracic × Clear all

NCT05852990 2025-05-01

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung